<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Griessmair M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Molecular glioblastoma (molGB) does not exhibit the histologic hallmarks of a grade 4 glioma but is nevertheless diagnosed as glioblastoma when harboring specific molecular markers. MolGB can easily be mistaken for similar-appearing lower-grade astrocytomas. Here, we investigated how advanced imaging could reflect the underlying tumor biology.&lt;h4>Methods&lt;/h4>Clinical and imaging data were collected for 7 molGB grade 4, 9 astrocytomas grade 2, and 12 astrocytomas grade 3. Four neuroradiologists performed VASARI-scoring of conventional imaging, and their inter-reader agreement was assessed using Fleiss κ coefficient. To evaluate the potential of advanced imaging, 2-sample &lt;i>t&lt;/i> test, 1-way ANOVA, Mann-Whitney U, and Kruskal-Wallis test were performed to test for signifi</pubmed_abstract><journal>Neuro-oncology advances</journal><pagination>vdae106</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11304596</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology.</pubmed_title><pmcid>PMC11304596</pmcid><pubmed_authors>Bernhardt D</pubmed_authors><pubmed_authors>Meyer B</pubmed_authors><pubmed_authors>Kertels O</pubmed_authors><pubmed_authors>Schramm S</pubmed_authors><pubmed_authors>Jung K</pubmed_authors><pubmed_authors>Griessmair M</pubmed_authors><pubmed_authors>Schmidt-Graf F</pubmed_authors><pubmed_authors>Metz MC</pubmed_authors><pubmed_authors>Yakushev I</pubmed_authors><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Ziegenfeuter J</pubmed_authors><pubmed_authors>Delbridge C</pubmed_authors><pubmed_authors>Zimmer C</pubmed_authors><pubmed_authors>Wiestler B</pubmed_authors><pubmed_authors>Combs SE</pubmed_authors><pubmed_authors>Mueller T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology.</name><description>&lt;h4>Background&lt;/h4>Molecular glioblastoma (molGB) does not exhibit the histologic hallmarks of a grade 4 glioma but is nevertheless diagnosed as glioblastoma when harboring specific molecular markers. MolGB can easily be mistaken for similar-appearing lower-grade astrocytomas. Here, we investigated how advanced imaging could reflect the underlying tumor biology.&lt;h4>Methods&lt;/h4>Clinical and imaging data were collected for 7 molGB grade 4, 9 astrocytomas grade 2, and 12 astrocytomas grade 3. Four neuroradiologists performed VASARI-scoring of conventional imaging, and their inter-reader agreement was assessed using Fleiss κ coefficient. To evaluate the potential of advanced imaging, 2-sample &lt;i>t&lt;/i> test, 1-way ANOVA, Mann-Whitney U, and Kruskal-Wallis test were performed to test for signifi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan-Dec</publication><modification>2025-04-26T05:32:18.372Z</modification><creation>2025-04-06T11:29:14.69Z</creation></dates><accession>S-EPMC11304596</accession><cross_references><pubmed>39114182</pubmed><doi>10.1093/noajnl/vdae106</doi></cross_references></HashMap>